Company: SINT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024040
Chunk: 23

Company: Sintx Technologies, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 8
Chunk 23
---
25%
  
    Loss from operations 
     (2,665) 
     (2,710) 
     45  
     -2% 
     (5,048) 
     (5,907) 
     859  
     -15%
  
    Other income (expense) 
     347  
     506  
     (159) 
     -31% 
     438  
     2,817  
     (2,379) 
     -84%
  
    Net loss before taxes 
     (2,318) 
     (2,204) 
     (114) 
     5% 
     (4,610) 
     (3,090) 
     (1,520) 
     49%
  
    Provision for income taxes 
     -  
     -  
     -  
     -% 
     -  
     -  
     -  
     -%
  
    Net loss 
    $(2,318) 
    $(2,204) 
    $(114) 
     5% 
    $(4,610) 
    $(3,090) 
    $(1,520) 
     49%

Revenue

For
the three months ended June 30, 2025, product revenue decreased $0.3 million, or 74%, compared to the same period in 2024. During
the three months ended June 30, 2025, grant and contract revenue decreased $0.4 million, or 89% as compared to the same period in
2024.

For
the six months ended June 30, 2025, product revenue decreased $0.3 million, or 43%, compared to the same period in 2024. During the
six months ended June 30, 2025, grant and contract revenue decreased $0.7 million, or 85% as compared to the same period in
2024.

Revenue
trends and strategic focus

The decrease in total revenue for the two periods was primarily due to
the Company’s ongoing strategic repositioning away from non-core, low-margin OEM technical manufacturing contracts that did not
support long-term profitability. This planned reduction in OEM-related revenue is consistent with our corporate shift toward commercializing
proprietary silicon nitride-based biomedical devices, which we believe